Small Cell Lung Cancer Clinical Trials

641 clinical trials for Small Cell Lung Cancer across international registries, including 144 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer — RECRUITING · PHASE3
• A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody Drug Conjugate (ADC), Compared to Investigator’s Choice Therapy in Participants with Relapsed Small Cell Lung Cancer — RECRUITING · PHASE3
• A Phase 2 diagnostic study with 68Ga-EVG321 in Patients with Small Cell Lung Cancer — RECRUITING · PHASE2
• DAREON®-Lung-1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer. — RECRUITING · PHASE3
• PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 — RECRUITING · PHASE1
• Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy — RECRUITING · NA
• Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial) — RECRUITING · PHASE1
• NK Cells Plus ICI for SCLC Maintenance — RECRUITING · PHASE2
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — RECRUITING · PHASE1
• Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) — RECRUITING · PHASE1
• Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors — RECRUITING
• DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy — RECRUITING · PHASE3
• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer — RECRUITING · PHASE3
• Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC) — RECRUITING · PHASE1
• DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer — RECRUITING · PHASE1
• Tarlatamab for SCLC Brain Metastases — RECRUITING · PHASE2
• Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer — RECRUITING · PHASE2
• A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma — RECRUITING · PHASE1
• Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer — RECRUITING · PHASE1
• DESTINY-PANTUMOUR04 — RECRUITING
• Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer — RECRUITING · PHASE2
• A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) — RECRUITING · PHASE3
• Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis — RECRUITING · PHASE1
• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — RECRUITING · PHASE3
• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) — RECRUITING · PHASE1
• Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer — RECRUITING
• TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO — RECRUITING
• Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer — RECRUITING · PHASE1
• A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer — RECRUITING · PHASE1
• LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE) — RECRUITING · NA
• A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• A Study of DXC014 in Patients With Advanced Solid Tumors. — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) — RECRUITING · PHASE1
• DLL3-Targeted PET/CT in Small Cell Lung Cancer — RECRUITING · NA
• Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer — RECRUITING · PHASE2
• A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors — RECRUITING · PHASE1
• 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer — RECRUITING · PHASE1
• Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer — RECRUITING · PHASE1
• Tempus Small Cell Lung Cancer Observational Study (Sculptor) — RECRUITING
• THE-0504 in Patients With Solid Tumors — RECRUITING · PHASE1
• A Study of Hospital-at-Home for People Receiving Tarlatamab — RECRUITING · NA
• Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors — RECRUITING · PHASE1
• A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain — RECRUITING · PHASE2
• Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab — RECRUITING · PHASE2
• A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• Safety and Preliminary Activity of BI115 in Advanced SCLC — RECRUITING · PHASE1

Refine this search